Recombinant Human PDIA3 Protein，His

PDIA3 (Protein Disulfide Isomerase A3) is a member of the protein disulfide isomerase family, which plays a crucial role in the folding and maturation of proteins in the endoplasmic reticulum (ER). Research on PDIA3 has gained significant attention due to its involvement in various cellular processes, including protein quality control, ER stress response, and apoptosis. Under pathological conditions, PDIA3 has been implicated in the progression of several diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases, where its overexpression or dysfunction can affect cell survival and tissue homeostasis. The ability of PDIA3 to facilitate disulfide bond formation and rearrangement is particularly valuable for therapeutic interventions, as modulating its activity could lead to improved outcomes in diseases characterized by protein misfolding. Recent studies have focused on the structural and functional characterization of PDIA3, including the development of recombinant forms of the protein. These recombinant proteins are essential for investigating PDIA3's catalytic mechanisms and interactions with other cellular molecules. By generating PDIA3 recombinants, researchers aim to delineate its roles in both normal physiological processes and disease states, paving the way for novel therapeutic strategies that harness PDIA3's unique properties for targeted treatment of diseases resulting from protein misfolding or dysregulation. Thus, the exploration of PDIA3 recombinant proteins is poised to enhance our understanding of cellular protein homeostasis and its broader implications in health and disease.